95 related articles for article (PubMed ID: 16541142)
1. Unsupervised proteome analysis of human leukaemia cells identifies the Valosin-containing protein as a putative marker for glucocorticoid resistance.
Lauten M; Schrauder A; Kardinal C; Harbott J; Welte K; Schlegelberger B; Schrappe M; von Neuhoff N
Leukemia; 2006 May; 20(5):820-6. PubMed ID: 16541142
[TBL] [Abstract][Full Text] [Related]
2. Protein expression of the glucocorticoid receptor in childhood acute lymphoblastic leukemia.
Lauten M; Cario G; Asgedom G; Welte K; Schrappe M
Haematologica; 2003 Nov; 88(11):1253-8. PubMed ID: 14607754
[TBL] [Abstract][Full Text] [Related]
3. Kinetics of the in vivo expression of glucocorticoid receptor splice variants during prednisone treatment in childhood acute lymphoblastic leukaemia.
Lauten M; Fernandez-Munoz I; Gerdes K; von Neuhoff N; Welte K; Schlegelberger B; Schrappe M; Beger C
Pediatr Blood Cancer; 2009 Apr; 52(4):459-63. PubMed ID: 19061214
[TBL] [Abstract][Full Text] [Related]
4. Expression of heat-shock protein 90 in glucocorticoid-sensitive and -resistant childhood acute lymphoblastic leukaemia.
Lauten M; Beger C; Gerdes K; Asgedom G; Kardinal C; Welte K; Schrappe M
Leukemia; 2003 Aug; 17(8):1551-6. PubMed ID: 12886242
[TBL] [Abstract][Full Text] [Related]
5. Initial leukemic gene expression profiles of patients with poor in vivo prednisone response are similar to those of blasts persisting under prednisone treatment in childhood acute lymphoblastic leukemia.
Cario G; Fetz A; Bretscher C; Möricke A; Schrauder A; Stanulla M; Schrappe M
Ann Hematol; 2008 Sep; 87(9):709-16. PubMed ID: 18521602
[TBL] [Abstract][Full Text] [Related]
6. Clinical outcome of patients with childhood acute lymphoblastic leukaemia and an initial leukaemic blood blast count of less than 1000 per microliter.
Lauten M; Stanulla M; Zimmermann M; Welte K; Riehm H; Schrappe M
Klin Padiatr; 2001; 213(4):169-74. PubMed ID: 11528550
[TBL] [Abstract][Full Text] [Related]
7. mRNA expression levels of (co)chaperone molecules of the glucocorticoid receptor are not involved in glucocorticoid resistance in pediatric ALL.
Tissing WJ; Meijerink JP; den Boer ML; Brinkhof B; Pieters R
Leukemia; 2005 May; 19(5):727-33. PubMed ID: 15759037
[TBL] [Abstract][Full Text] [Related]
8. Association of initial response to prednisone treatment in childhood acute lymphoblastic leukaemia and polymorphisms within the tumour necrosis factor and the interleukin-10 genes.
Lauten M; Matthias T; Stanulla M; Beger C; Welte K; Schrappe M
Leukemia; 2002 Aug; 16(8):1437-42. PubMed ID: 12145682
[TBL] [Abstract][Full Text] [Related]
9. XIAP expression is post-transcriptionally upregulated in childhood ALL and is associated with glucocorticoid response in T-cell ALL.
Hundsdoerfer P; Dietrich I; Schmelz K; Eckert C; Henze G
Pediatr Blood Cancer; 2010 Aug; 55(2):260-6. PubMed ID: 20582956
[TBL] [Abstract][Full Text] [Related]
10. Differential mRNA expression of glucocorticoid receptor alpha and beta is associated with glucocorticoid sensitivity of acute lymphoblastic leukemia in children.
Koga Y; Matsuzaki A; Suminoe A; Hattori H; Kanemitsu S; Hara T
Pediatr Blood Cancer; 2005 Aug; 45(2):121-7. PubMed ID: 15704223
[TBL] [Abstract][Full Text] [Related]
11. Alterations in gamma-actin and tubulin-targeted drug resistance in childhood leukemia.
Verrills NM; Po'uha ST; Liu ML; Liaw TY; Larsen MR; Ivery MT; Marshall GM; Gunning PW; Kavallaris M
J Natl Cancer Inst; 2006 Oct; 98(19):1363-74. PubMed ID: 17018783
[TBL] [Abstract][Full Text] [Related]
12. Proteomic analysis reveals a novel role for the actin cytoskeleton in vincristine resistant childhood leukemia--an in vivo study.
Verrills NM; Liem NL; Liaw TY; Hood BD; Lock RB; Kavallaris M
Proteomics; 2006 Mar; 6(5):1681-94. PubMed ID: 16456880
[TBL] [Abstract][Full Text] [Related]
13. Cytotoxicity of cortivazol in childhood acute lymphoblastic leukemia.
Styczynski J; Kurylak A; Wysocki M
Anticancer Res; 2005; 25(3B):2253-8. PubMed ID: 16158972
[TBL] [Abstract][Full Text] [Related]
14. Gene expression shift towards normal B cells, decreased proliferative capacity and distinct surface receptors characterize leukemic blasts persisting during induction therapy in childhood acute lymphoblastic leukemia.
Rhein P; Scheid S; Ratei R; Hagemeier C; Seeger K; Kirschner-Schwabe R; Moericke A; Schrappe M; Spang R; Ludwig WD; Karawajew L
Leukemia; 2007 May; 21(5):897-905. PubMed ID: 17330098
[TBL] [Abstract][Full Text] [Related]
15. Expression and structural analysis of glucocorticoid receptor isoform gamma in human leukaemia cells using an isoform-specific real-time polymerase chain reaction approach.
Beger C; Gerdes K; Lauten M; Tissing WJ; Fernandez-Munoz I; Schrappe M; Welte K
Br J Haematol; 2003 Jul; 122(2):245-52. PubMed ID: 12846893
[TBL] [Abstract][Full Text] [Related]
16. Bortezomib Treatment can Overcome Glucocorticoid Resistance in Childhood B-cell Precursor Acute Lymphoblastic Leukemia Cell Lines.
Junk S; Cario G; Wittner N; Stanulla M; Scherer R; Schlegelberger B; Schrappe M; von Neuhoff N; Lauten M
Klin Padiatr; 2015 May; 227(3):123-30. PubMed ID: 25985447
[TBL] [Abstract][Full Text] [Related]
17. Glucocorticoid resistance in paediatric acute lymphoblastic leukaemia.
Bhadri VA; Trahair TN; Lock RB
J Paediatr Child Health; 2012 Aug; 48(8):634-40. PubMed ID: 22050419
[TBL] [Abstract][Full Text] [Related]
18. Resistance to glucocorticoids in childhood acute lymphoblastic leukemia: impact of relationship between ex vivo sensitivity and in vivo concentration on risk factor analysis.
Styczynski J; Koltan A; Wysocki M
Neoplasma; 2006; 53(2):168-73. PubMed ID: 16575474
[TBL] [Abstract][Full Text] [Related]
19. [Prognostic value of the initial response to corticosteroids for children with acute lymphoblastic leukemia].
Klimza MJ; Sońta-Jakimczyk DJ
Wiad Lek; 2005; 58(11-12):622-5. PubMed ID: 16594471
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic value of the dual-luciferase report assay for predicting response to glucocorticoid in children with acute lymphoblastic leukemia.
Wang X; Chen P; Sun Y; Chen Y; Mao M; Jiang T; Ouyang J
Clin Transl Oncol; 2017 Oct; 19(10):1241-1246. PubMed ID: 28444640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]